Nuveen’s Regulus Therapeutics RGLS Stock Holding History

Nuveen’s Portfolio RGLS Stock Details RGLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-85,602	Closed	-$150K	–	3389
2025 Q1	$150K	Hold	85,602	–	–	﹤0.01%	3166
2024 Q4	$135K	Hold	85,602	–	–	﹤0.01%	3264
2024 Q3	$134K	Hold	85,602	–	–	﹤0.01%	3283
2024 Q2	$153K	Buy	+85,602	New	+$199K	﹤0.01%	3262

Other funds holding RGLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Nuveen's RGLS Position: Q2 2025 in Review

Nuveen sold out of Regulus Therapeutics (RGLS) in Q2 2025, closing a stake of 85,602 shares — an estimated $150K sold.

Nuveen first reported a position in RGLS in Q2 2024 and held it in 4 quarters. The position peaked at $153K in Q2 2024. 0 funds tracked by Wall St. Rank hold RGLS as of Q2 2025.

Nuveen reported no remaining Regulus Therapeutics position as of Q2 2025 after selling out during the quarter.
Nuveen sold 85,602 Regulus Therapeutics shares in Q2 2025, an estimated $150K.
Nuveen first reported a position in Regulus Therapeutics in Q2 2024 and held it in 4 quarters.
Nuveen's Regulus Therapeutics position peaked at $153K in Q2 2024.
0 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.